Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

INR: Intervals of measurement can safely extend to 14 weeks.

Lidstone V, Janes S, Stross P.

Clin Lab Haematol. 2000 Oct;22(5):291-3.

PMID:
11122271
2.

Outcomes and predictors of very stable INR control during chronic anticoagulation therapy.

Witt DM, Delate T, Clark NP, Martell C, Tran T, Crowther MA, Garcia DA, Ageno W, Hylek EM; Warfarin Associated Research Projects and other EnDeavors (WARPED) Consortium.

Blood. 2009 Jul 30;114(5):952-6. doi: 10.1182/blood-2009-02-207928. Epub 2009 May 13.

3.

Accuracy, reproducibility and clinical utility of the CoaguChek S portable international normalized ratio monitor in an outpatient anticoagulation clinic.

Jackson SL, Bereznicki LR, Peterson GM, Marsden KA, Jupe DM, Tegg E, Vial JH, Kimber RI.

Clin Lab Haematol. 2004 Feb;26(1):49-55.

PMID:
14738438
4.

Self-management of anticoagulation.

Levi M.

Expert Rev Cardiovasc Ther. 2008 Aug;6(7):979-85. doi: 10.1586/14779072.6.7.979. Review.

PMID:
18666848
5.

The interval between prothrombin time tests and the quality of oral anticoagulants treatment in patients with chronic atrial fibrillation.

Shalev V, Rogowski O, Shimron O, Sheinberg B, Shapira I, Seligsohn U, Berliner S, Misgav M.

Thromb Res. 2007;120(2):201-6. Epub 2006 Nov 21.

PMID:
17118431
6.
7.

Use of chromogenic assay of factor X to accept or reject INR results in Warfarin treated patients.

Sanfelippo MJ, Zinsmaster W, Scherr DL, Shaw GR.

Clin Med Res. 2009 Sep;7(3):103-5. doi: 10.3121/cmr.2009.836. Epub 2009 Jul 22.

8.

Anticoagulation monitoring part 1: warfarin and parenteral direct thrombin inhibitors.

Spinler SA, Nutescu EA, Smythe MA, Wittkowsky AK.

Ann Pharmacother. 2005 Jun;39(6):1049-55. Epub 2005 Apr 26. Review.

PMID:
15855245
9.

Evaluating the impact of study-level factors on warfarin control in U.S.-based primary studies: a meta-analysis.

Cios DA, Baker WL, Sander SD, Phung OJ, Coleman CI.

Am J Health Syst Pharm. 2009 May 15;66(10):916-25. doi: 10.2146/ajhp080507.

PMID:
19420310
10.

Search for predictors of nontherapeutic INR results with warfarin therapy.

McGriff-Lee NJ, Csako G, Chen JT, Dang DK, Rosenfeld KG, Cannon RO, Macklin LR, Wesley RA; Anticoagulation Working Group.

Ann Pharmacother. 2005 Dec;39(12):1996-2002. Epub 2005 Nov 15.

PMID:
16288081
11.

Accuracy of the CoaguChek XS for point-of-care international normalized ratio (INR) measurement in children requiring warfarin.

Bauman ME, Black KL, Massicotte MP, Bauman ML, Kuhle S, Howlett-Clyne S, Cembrowski GS, Bajzar L.

Thromb Haemost. 2008 Jun;99(6):1097-103. doi: 10.1160/TH07-10-0634.

PMID:
18521514
12.

Anticoagulation self-monitoring.

Pence C, McErlane K.

Am J Nurs. 2005 Oct;105(10):62-5. Review.

PMID:
16205413
13.

The necessity to assess anticoagulation status in elderly injured patients.

Williams TM, Sadjadi J, Harken AH, Victorino GP.

J Trauma. 2008 Oct;65(4):772-6; discussion 776-7. doi: 10.1097/TA.0b013e3181877ff7.

PMID:
18849789
14.

Evaluation of the phospholipid-rich dilute Russell's viper venom assay to monitor oral anticoagulation in patients with lupus anticoagulant.

Thom J, Ivey L, Gilmore G, Eikelboom JW.

Blood Coagul Fibrinolysis. 2004 Jun;15(4):353-7.

PMID:
15166923
15.

Minor oral surgery and interference with anticoagulation in patients taking warfarin: a retrospective study.

Malden NJ, Santini A, Mather CI, Gardner A.

Br J Oral Maxillofac Surg. 2007 Dec;45(8):645-7. Epub 2007 Aug 1.

PMID:
17683833
16.

Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.

Clark NP, Witt DM, Delate T, Trapp M, Garcia D, Ageno W, Hylek EM, Crowther MA; Warfarin-Associated Research Projects and Other Endeavors Consortium.

Pharmacotherapy. 2008 Aug;28(8):960-7. doi: 10.1592/phco.28.8.960.

PMID:
18657012
17.

Warfarin treatment in patients with atrial fibrillation: observing outcomes associated with varying levels of INR control.

Morgan CL, McEwan P, Tukiendorf A, Robinson PA, Clemens A, Plumb JM.

Thromb Res. 2009 May;124(1):37-41. doi: 10.1016/j.thromres.2008.09.016. Epub 2008 Dec 4.

PMID:
19062079
18.

Oral anticoagulation thresholds.

Brummel KE, Paradis SG, Branda RF, Mann KG.

Circulation. 2001 Nov 6;104(19):2311-7.

19.

Phase 1 drug interaction study of suramin and warfarin in patients with prostate cancer.

Meyer M, Jeong E, Bolinger B, Chen L, Lenehan P, Slichenmyer W, Natale RB.

Am J Clin Oncol. 2001 Apr;24(2):167-71.

PMID:
11319293
20.

[A study on anticoagulation for cardiovascular diseases using international normalized ratio (INR)].

Izumi Y, Asada H, Hoshino Z, Yoshida H, Kubota H.

Kyobu Geka. 1996 Nov;49(12):997-1000. Japanese.

PMID:
8937001

Supplemental Content

Support Center